Glaucoma News and Research

Latest Glaucoma News and Research

Glaucoma procedure Trabectome now available at Mayo Clinic

For the first time in Florida, patients with glaucoma have a new treatment option known as the Trabectome. The minimally invasive procedure, which is available at Mayo Clinic and takes about 20 minutes, is designed to decrease pressure within the eye and stabilize the vision.

26 Jun 2008

New findings on vitamin E and cataracts in women

A new analysis of the Women's Health Study (WHS) found that women who took Vitamin E supplements had rates of cataract development comparable to women who did not take such supplements.

1 May 2008

Dallas area cornea shortages could benefit from national study

Surgeons and patients from UT Southwestern Medical Center and UT Southwestern Transplant Services Center joined in a landmark study showing that corneas from older donors are as successful for transplants after five years as is tissue from younger donors, allowing possible expansion of the donor pool.

2 Apr 2008

Easter eye warning as occy straps lash out

Easter-period travellers are being warned to take care with octopus straps that hospitalise 540 people each year with severe eye injuries.

21 Mar 2008

NicOx signs agreement for commercial manufacture of Naproxcinod drug substance

NicOx S.A. (Euronext Paris: COX) has announced it has signed an agreement with the fine chemical company Archimica, for the commercial manufacturing and supply of naproxcinod drug substance (or active pharmaceutical ingredient, API).

20 Mar 2008

Glaucoma associated with increased risk of cardiovascular death in black patients

In a population of African origin, persons with diagnosed and treated glaucoma appeared to have an increased risk of death from cardiovascular causes, according to a study by Suh-Yuh Wu, and colleagues in the Departments of Preventive Medicine and Ophthalmology at Stony Brook University, the University of the West Indies, and the Cleveland Clinic Foundation.

12 Mar 2008

Glaucoma associated with increased risk of cardiovascular death in black patients

Black patients with diagnosed and treated glaucoma and those with high pressure in their eyes appear to have an increased risk of death from cardiovascular causes, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

11 Mar 2008

Are cataract rates on the decline?

Should glaucoma patients seeking alternative therapies trust what they find online? Are seatbelts still important to protect eyes in auto accidents, now that most cars have airbags? What's the connection between hearing loss and one form of glaucoma? These are among the topics explored in the March 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.

28 Feb 2008

New metabolic imaging instrument shows promise as screening device in diabetes and other major eye diseases

Scientists at the University of Michigan have shown that their new metabolic imaging instrument can accurately detect eye disease at a very early stage.

26 Feb 2008

Role gound for glaucoma gene and a signaling pathway

Researchers have found that a gene and a related signaling pathway play a role in the development of glaucoma, which is a common cause of visual impairment and blindness worldwide.

18 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008

Trabectome procedure for glaucoma

Glaucoma is a devastating disease that harms the eye without manifesting early signs or symptoms.

4 Feb 2008

Special report on the aging eye

Cataract surgery involves removing a clouded natural lens from inside the eye and replacing it with a plastic one.

21 Jan 2008

New European medical implants

Patients suffering from conditions such as stroke, blindness, deafness, incontinence, glaucoma or hydrocephalus will be the first to benefit from a range of new technologies and implantable medical devices developed by a pioneering European consortium of researchers, surgeons and technology companies.

16 Jan 2008

NicOx extends ophthalmology agreement with Pfizer

NicOx S.A. has announced it has signed an extension of its March 2006 collaboration agreement, which grants Pfizer Inc the exclusive right to apply its proprietary nitric oxide-donating technology to drug discovery research in the field of ophthalmology.

9 Jan 2008

Early detection is critical to treating glaucoma

Early detection is critical to maintain healthy vision. With almost two-thirds of adult Americans, who do not wear corrective lenses, not receiving regular comprehensive eye exams, millions of people are putting their vision and their quality of life at risk, according to the American Optometric Association.

4 Jan 2008

Immune system may target some brain synapses

A baby's brain has a lot of work to do, growing more neurons and connections.

14 Dec 2007

Functional magnetic resonance imaging aids study of brain development

Functional magnetic resonance imaging (fMRI) is a powerful noninvasive tool for studying brain activity in both humans and experimental animals.

3 Dec 2007

Visual field loss increases the risk of falls in older adults

Visual field loss (specifically peripheral visual fields) is the primary vision component that increases the risk of falls, according to a study published this month in Investigative Ophthalmology and Vision Science, a peer-reviewed monthly publication of the Association for Research in Vision and Ophthalmology (ARVO).

31 Oct 2007

Visual field loss increases risk of falls in older adults

Rockville, MD þu Visual field loss (specifically peripheral visual fields) is the primary vision component that increases the risk of falls, according to a study published this month in Investigative Ophthalmology and Vision Science, a peer-reviewed monthly publication of the Association for Research in Vision and Ophthalmology (ARVO).

29 Oct 2007